Adaptimmune Announces Closing Of $42 Million Registered Direct Offering Post author:Sam Post published:April 10, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Pressure BioSciences, Inc. Achieves CE Marking For Its Next Generation Sample Preparation Instrument, The Barocycler 2320EXTREME February 1, 2017 Amag Investors Cheer as Biotech Wins Second Drug Approval This Month February 15, 2018 These 3 Gene Therapy Biotechs Could Make Investors Rich October 22, 2017
Pressure BioSciences, Inc. Achieves CE Marking For Its Next Generation Sample Preparation Instrument, The Barocycler 2320EXTREME February 1, 2017